🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Richard Pzena’s SNY Holdings & Trades

First Buy
Q1 2025
Duration Held
5 Quarters
Largest Add
Q1 2026
+7,339 Shares
Current Position
19,088 Shares
$919,636 Value

Richard Pzena's SNY Position Overview

Richard Pzena (via Pzena Investment Management LLC) currently holds 19,088 shares of Sanofi (SNY) worth $919,636, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.

Based on 13F filings, Richard Pzena has maintained this position in SNY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 7,339 shares.

Analysis based on 13F filings available since 2013 Q2

Richard Pzena's Sanofi (SNY) Holding Value Over Time

Track share changes against reported price movement

Quarterly Sanofi (SNY) Trades by Richard Pzena

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +7,339 Add 62.46% 19,088 $48.18
Q4 2025 +5,083 Add 76.25% 11,749 $48.46
Q3 2025 +1,086 Add 19.46% 6,666 $47.20
Q2 2025 +195 Add 3.62% 5,580 $48.31
Q1 2025 +5,385 New Buy 5,385 $55.46

Richard Pzena's Sanofi Investment FAQs

Richard Pzena first purchased Sanofi (SNY) in Q1 2025, acquiring 5,385 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Richard Pzena has held Sanofi (SNY) for 5 quarters since Q1 2025.

Richard Pzena's largest addition to Sanofi (SNY) was in Q1 2026, adding 19,088 shares worth $919,636.

According to the latest 13F filing for Q1 2026, Richard Pzena's firm, Pzena Investment Management LLC, owns 19,088 shares of Sanofi (SNY), valued at approximately $919,636.

As of the Q1 2026 filing, Sanofi (SNY) represents approximately 0.00% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings.

Richard Pzena's peak holding in Sanofi (SNY) was 19,088 shares, as reported at the end of Q1 2026.